These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT, Hagie F, Keen CL, Gershwin ME. Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [Abstract] [Full Text] [Related]
5. The right to a trial: Should dying patients have access to experimental drugs? Groopman J. New Yorker; 2006 Dec 18; ():40-7. PubMed ID: 17176539 [No Abstract] [Full Text] [Related]
6. Evidence used for approval of new drugs. Botstein P. Isr J Med Sci; 1986 Dec 18; 22(3-4):197-200. PubMed ID: 3528042 [Abstract] [Full Text] [Related]
13. Medical marijuana: the conflict between scientific evidence and political ideology. Part one of two. Cohen PJ. J Pain Palliat Care Pharmacother; 2009 Dec 18; 23(1):4-25. PubMed ID: 19296351 [Abstract] [Full Text] [Related]
15. New drug development. Taylor WJ. Int Z Klin Pharmakol Ther Toxikol; 1969 Apr 18; 2(2):105-13. PubMed ID: 4895441 [No Abstract] [Full Text] [Related]
18. Rules and regulations for the production of allergenic extracts: past, present, future. Brede HD. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1985 Apr 18; (79):3-9. PubMed ID: 4051495 [No Abstract] [Full Text] [Related]
19. Anticancer Drug Development: The Way Forward. Connors T. Oncologist; 1996 Apr 18; 1(3):180-181. PubMed ID: 10387985 [Abstract] [Full Text] [Related]